M.D. Anderson Cancer Center Newswire (Page 3)

M.D. Anderson Cancer Center Newswire (Page 3)

Comprehensive Real-Time News Feed for M.D. Anderson Cancer Center. (Page 3)

Results 41 - 60 of 3,189 in M.D. Anderson Cancer Center

  1. BioLineRx Reports Second Quarter 2016 Financial ResultsRead the original story

    Wednesday Aug 10 | BioSpace

    TEL AVIV, Israel, Aug. 11, 2016 /PRNewswire/ -- BioLineRx Ltd. , a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, today reports its financial results for the second quarter ended June 30, 2016.

    Comment?

  2. Dr. Emil Freireich attacked cancer on multiple frontsRead the original story w/Photo

    Wednesday Aug 10 | Chron

    ... blood banks, separates components in the blood that will be transfused to patients. photo credit M.D. Anderson Cancer Center Archives Dr. Emil J Freireich sitting at the Vivo Blood Cell Separator, 1966, print no. 6612-0135 less Emil Freireich, whose ...

    Comment?

  3. Jacksonville patient spreading the word: Yes, non-smokers can get lung cancerRead the original story w/Photo

    Wednesday Aug 10 | The Florida Times-Union

    Baptist MD Anderson Cancer Center The center is at 1235 San Marco Blvd., Jacksonville, FL 32207. To request an appointment call 632-2278 or go to

    Comment?

  4. Living Legend Luncheon to Honor Kenneth H. Cooper, M.D., M.P.H. In DallasRead the original story

    Wednesday Aug 10 | Newswise

    The 27th annual A Conversation With a Living LegendA in Dallas, Sept. 28 at the Hilton Anatole, will honor Kenneth H. Cooper, M.D., M.P.H., founder of The Cooper Clinic and The Cooper Institute.

    Comment?

  5. ISCT selects London as host city for 2017 landmark conference to celebrate silver jubilee yearRead the original story w/Photo

    Wednesday Aug 10 | Medical News

    The International Society for Cellular Therapy , the global society of clinicians, researchers, regulatory specialists, technologists, and industry partners dedicated to the translation of cellular therapy into safe and effective therapies to improve patients' lives, today announces they have awarded London as the host city for the landmark ISCT 2017 Annual Meeting to be held on May 3-6, at ExCeL London Exhibition and Convention Centre, UK to celebrate the Society's 25th silver jubilee year. More than 1,600 international delegates are expected to attend.

    Comment?

  6. Tomas stays cancer-freeRead the original story w/Photo

    Tuesday Aug 9 | Sun-Star

    A text message was sent by the mayor yesterday to all the Bando Osmena Pundok Kauswagan members informing them of the result of his annual medical checkup at the M.D. Anderson Cancer Center in Houston, Texas. "All clear, no sign of cancer.

    Comment?

  7. Research reveals patient can have more than one breast cancer, points at treatmentsRead the original story w/Photo

    Monday Aug 8 | EurekAlert!

    Breast cancer tumors are complex and dynamic. They comprise a population of continuously dividing cells that carry different genetic mutations.

    Comment?

  8. Baptist Health Plans Massive DT ExpansionRead the original story w/Photo

    Tuesday Aug 9 | Metro Jacksonville

    Across the country, medical center expansion projects are being utilized as a catalyst for creating healthy communities where walkability and social engagement become a part of the economic transformation. In Orlando, Florida Hospital is in the midst of turning its campus, anchored by a Sunrail commuter rail station, into a 172-acre mixed-use transit oriented development called Health Village .

    Comment?

  9. BioLineRx Signs Second Clinical Immuno-Oncology Collaboration...Read the original story

    Sunday Aug 7 | BioSpace

    The study will be conducted as an investigator-sponsored study, as part of a strategic clinical research collaboration between MSD and MD Anderson Cancer Center aimed at evaluating Merck's anti-PD-1 therapy, KEYTRUDA, in combination with various treatments and novel drugs. The open-label, single center, single-arm Phase 2 study aims to evaluate the potential of BL-8040 with KEYTRUDA in pancreatic cancer and will focus on the mechanism of action by which both drugs might synergize.

    Comment?

  10. Cancer center partnershipadvantageousRead the original story w/Photo

    Friday Aug 5 | MySanAntonio.com

    A partner ship between San Antonio's Cancer Treatment & Research Center and MD Anderson Cancer Center - its Sheikh Zayed Bin Sultan Al Nahyan Building for Personal ized Cancer Care is shown here - makes sense. less A partner ship between San Antonio's Cancer Treatment & Research Center and MD Anderson Cancer Center - its Sheikh Zayed Bin Sultan Al Nahyan Building for Personal ized Cancer Care is shown here - makes ... more There is much to gain by having the University of Texas Health Science Center and MD Anderson, the top-ranked cancer-treatment hospital in the country, collaborate on expanding the services available in San Antonio.

    Comment?

  11. Scientists develop novel multifunctional platform to integrate...Read the original story w/Photo

    Friday Aug 5 | Medical News

    Physicists from The University of Texas at Arlington are leading a multidisciplinary project with The University of Texas Southwestern Medical Center in Dallas and The University of Texas MD Anderson Cancer Center in Houston to develop a new multifunctional platform that can integrate imaging and photo-induced cancer therapy in a single, portable device. The process of destroying cancer cells by utilizing chemicals or heat generated by nanoparticles induced by near-infrared light - through processes including photodynamic therapy and photothermal therapy - has shown great promise as a treatment option, along with surgery, radiation therapy and chemotherapy.

    Comment?

  12. Tax-Free Weekend: Shop Aug. 5-7Read the original story w/Photo

    Friday Aug 5 | Chron

    As students emotionally prepare themselves for the upcoming school year, Tax-Free Weekend gives parents a break as they financially prepare themselves for all the back to school shopping. Shop Aug. 5-7 to get deals on items priced under $100.

    Comment?

  13. UT Southwestern's kidney cancer research gets $11 million boost from NIHRead the original story

    Friday Aug 5 | Dallas Morning News

    UT Southwestern's Harold C. Simmons Comprehensive Cancer Center was awarded an $11 million grant from the National Institutes of Health to research Kidney Cancer. The Harold C. Simmons Comprehensive Cancer Center at UT Southwestern is set to receive $11 million from the National Institutes of Health to support kidney cancer research.

    Comment?

  14. Scientists identify marker for myeloid-derived suppressor cellsRead the original story w/Photo

    Friday Aug 5 | PhysOrg Weblog

    Typical staining of tumor tissues. Scale bars, 100 I1 4m. Credit: Condamine et al., Sci.

    Comment?

  15. 5 Blood Tests You Need After Age 50Read the original story w/Photo

    Friday Aug 5 | MSN Healthy Living

    Recently, the CDC reported new surveillance data showing an all-time high of hepatitis C-related deaths in 2014, at 19,659. Because the liver disease often doesn't cause any symptoms, many people might not even know they carry the virus or that they should be tested for it.

    Comment?

  16. UTA leads project to develop new device to deliver photo-induced cancer therapyRead the original story w/Photo

    Thursday Aug 4 | EurekAlert!

    Physicists from The University of Texas at Arlington are leading a multidisciplinary project with The University of Texas Southwestern Medical Center in Dallas and The University of Texas MD Anderson Cancer Center in Houston to develop a new multifunctional platform that can integrate imaging and photo-induced cancer therapy in a single, portable device. The process of destroying cancer cells by utilizing chemicals or heat generated by nanoparticles induced by near-infrared light - through processes including photodynamic therapy and photothermal therapy - has shown great promise as a treatment option, along with surgery, radiation therapy and chemotherapy.

    Comment?

  17. Coast a medical citya at Tradition one step closerRead the original story w/Photo

    Thursday Aug 4 | Sunherald.com

    A planned 'medical city' complex at Tradition in Harrison County calls for a National Diabetes & Obesity Research Institute research facility, William Carey University's Pharmacy School, the Mississippi Gulf Coast Community College Nursing School, a Coastal Family Health Center and student housing. Coast legislators, business leaders and city, county and state officials gather for the announcement of a 'medical city' complex at Tradition in Harrison County on Thursday, Aug. 5, 2016.

    Comment?

  18. Vaxil Announces Key U.S. Patent And Trademark Office Notice Of Allowance For Its ImmunotherapyRead the original story

    Wednesday Aug 3 | BioSpace

    VAXIL BIO ,a biotechnology company specializing in immunotherapy, announces today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent providing broad coverage over Vaxil's immunotherapy platform and its lead product, Orphan Drug Designated Immucina . This will become the first US Patent issued to Vaxil since the Company began developing its immunotherapies 10 years ago.

    Comment?

  19. Beating cancer part of U.S. athletes Rio journeyRead the original story w/Photo

    Thursday Aug 4 | USA Today

    Beating cancer is part of U.S. rugby player's journey to Rio Olympics Jillion Potter was diagnosed in 2014, but her work ethic helped her make U.S. team. Check out this story on USATODAY.com: http://usat.ly/2aG89UZ LOS ANGELES - From Jillion Potter's standpoint, 2014 was a great year.

    Comment?

  20. Vaxil Announces Key US Patent and Trademark Office Notice of Allowance for Its ImmunotherapyRead the original story w/Photo

    Thursday Aug 4 | Market Wire

    VAXIL BIO ,a biotechnology company specializing in immunotherapy, announces today that it has received a Notice of Allowance from the U.S. Patent and Trademark Office for a patent providing broad coverage over Vaxil's immunotherapy platform and its lead product, Orphan Drug Designated Immucina . This will become the first US Patent issued to Vaxil since the Company began developing its immunotherapies 10 years ago.

    Comment?